PROKIDNEY CORP.
For the period ended Aug 12, 2025. Filed Aug 12, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Aug 12, 2025 · Filed Aug 12, 2025
Use the contents to explore the available documents and sections.
PROK$1.14+7.0%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except for share data)2
(in thousands, except for share data)2
| June 30, 2025 | December 31, 2024 | |
|---|---|---|
| (Unaudited) | ||
| Assets | ||
| Cash and cash equivalents | $84,940 | $99,120 |
| Marketable securities | 209,788 | 259,172 |
| Interest receivable | 1,775 | 2,447 |
| Prepaid assets | 2,300 | 4,192 |
| Prepaid clinical | 5,723 | 11,505 |
| Assets held for sale | 19,368 | 19,368 |
| Other current assets | 546 | 80 |
| Total current assets | 324,440 | 395,884 |
| Fixed assets, net | 43,525 | 42,222 |
| Right of use assets, net | 4,168 | 2,967 |
| Total assets | $372,133 | $441,073 |
| Liabilities and Stockholders' Deficit | ||
| Accounts payable | $2,443 | $3,633 |
| Lease liabilities | 903 | 765 |
| Accrued expenses and other | 24,916 | 31,137 |
| Income taxes payable | – | 682 |
| Total current liabilities | 28,262 | 36,217 |
| Income tax payable, net of current portion | 903 | 748 |
| Lease liabilities, net of current portion | 3,515 | 2,471 |
| Total liabilities | 32,680 | 39,436 |
| Commitments and contingencies | ||
| Redeemable noncontrolling interest | 1,341,953 | 1,396,591 |
| Stockholders’ deficit | ||
| Class A common stock, $0.0001 par value; 500,000,000 shares authorized; 133,418,957 and 128,054,417 issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 13 | 13 |
| Class B common stock, $0.0001 par value; 500,000,000 shares authorized; 159,288,931 and 163,693,707 issued and outstanding as of June 30, 2025 and December 31, 2024, respectively | 16 | 16 |
| Additional paid-in capital | 231,576 | 205,736 |
| Accumulated other comprehensive gain | 30 | 130 |
| Accumulated deficit | (1,234,135) | (1,200,849) |
| Total stockholders' deficit | (1,002,500) | (994,954) |
| Total liabilities and stockholders' deficit | $372,133 | $441,073 |
2 For presentation purposes, unless otherwise noted, “ordinary shares” before the domestication and “common stock” subsequent to the domestication are referred to herein as common stock
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.